Abstract Tribulus terrestris is a plant that has medical importance in treating diseases such as cancer, urinary tract infections, kidney stones, rheumatism, and hypertension. The aim of this study is to examine the effects of extraction methods/solvents on the biological activity and chemical content of the plant and then to determine ADMET predictions of phenolics that were analysed quantitatively using HPLC-DAD in the plant. Maceration methanol (IC50:0.277 mg/mL) and chloroform (0.263 mMFeSO4/mg extract) extracts were found to have the strongest DPPH radical scavenging and iron (III) ion reducing activity, respectively. It was determined that Soxhlet methanol (0.0225 mMTE/mg extract) and Soxhlet chloroform (1.360 mMTE/mg extract) extracts exhibited stronger radical cation (ABTS.+) scavenging and cupric ion reducing activity compared to other extracts, respectively. It was found that ultrasonic bath methanol extracts showed the highest anti-urease (21.47%) and calcium oxalate anti-crystallization (71.54%, 80.52%) activity. It was also found that Soxhlet methanol extract (66.763%) has strong acetylcholinesterase enzyme inhibition capacity compared to other extracts. Pyrocatechol, vanillic acid, vanillin, rutin and rosmarinic acid were analysed by HPLC-DAD in the plant. Moreover, it was determined that methanol extracts obtained using soxhlet, ultrasonic bath, and maceration contained the highest amount of rutin, pyrocatechol, and rutin, respectively. ADMET predictions of phenolics show that these compounds are easily absorbed and do not have toxic effects, suggesting that this species may be used as a natural medicinal and nutritional source in the future after detailed analysis tests.

RESUMO Objetivo: Comparar doses de 0,5 mg e 0,625 mg de bevacizumab no tratamento da retinopatia da prematuridade posterior agressiva (ROP-PA). Métodos: os registros médicos de pacientes com ROP-PA que receberam bevacizumab intravítreo (IVB) como tratamento primário em uma clínica universitária foram avaliados retrospectivamente. Houve 5 olhos de 3 casos (Grupo 1) que receberam 0,625 mg/0,025 ml de IVB e 10 olhos de outros 5 casos (Grupo 2) que receberam 0,5 mg/0,02 ml de IVB. A fotocoagulação com laser foi utilizada como tratamento adicional para casos de recidiva. Os resultados e complicações anatômicas foram avaliados em ambos os grupos. Resultados: Incluímos os 15 olhos de 8 pacientes (4 meninas e 4 meninos) com linha de demarcação plana na zona posterior 2 e doença "plus" (dilatação e tortuosidade vascular) neste estudo. A idade gestacional média dos três bebês no Grupo 1 foi de 26 ± 1 semana e o peso médio ao nascer foi de 835,33 ± 48,01 g, enquanto esses valores foram de 25,2 ± 1,6 semanas e 724 ± 139,03 g, respectivamente, para os cinco bebês do Grupo 2. A vascularização da retina foi completada com uma duração média pós-menstrual de 53,6 ± 1,5 semanas sem tratamento adicional nos cinco olhos no Grupo 1. A fotocoagulação a laser foi administrada devido à recaída em 5 dos 10 olhos do Grupo 2. A vascularização da retina foi completada em média de 47,6 ± 1,5 semanas do período pós-menstrual nos cinco olhos restantes. Nenhum dos casos desenvolveu complicações, como catarata, glaucoma, rasgo da retina, hemorragia retiniana ou vítrea ou descolamento da retina. Conclusão: Embora as doses mais baixas de IVB no tratamento de ROP-PA sejam mais seguras em termos de efeitos colaterais locais e sistêmicos em prematuros, esses pacientes podem precisar de tratamento adicional com IVB ou fotocoagulação a laser.

ABSTRACT Purpose: To compare 0.5 mg and 0.625 mg of bevacizumab for treating aggressive posterior retinopathy of prematurity (AP-ROP). Methods: The medical records of patients with AP-ROP who were administered intravitreal bevacizumab (IVB) as a primary treatment at a university clinic were evaluated retrospectively. Five eyes of three patients (Group 1) who received 0.625 mg/0.025 ml IVB and 10 eyes of another five patients (Group 2) who received 0.5 mg/0.02 ml IVB were evaluated. Laser photocoagulation was used as additional treatment after relapses. Anatomic results and complications were evaluated in both groups. Results: We evaluated 15 eyes of eight patients (four girls and four boys) with a flat demarcation line at posterior zone 2 and plus disease or stage-3 disease in this study. The mean gestational age of the three babies in Group 1 was 26 ± 1 weeks and the mean birth weight was 835.33 ± 48.01 g. The corresponding values were 25.2 ± 1.6 weeks and 724 ± 139.03 g, respectively, for the five babies in Group 2. Retinal vascularization was completed at a mean postmenstrual duration of 53.6 ± 1.5 weeks without additional treatment in the five eyes in Group 1. Laser photocoagulation for relapse was administered to five of the 10 eyes in Group 2. Retinal vascularization was completed at a mean postmenstrual duration of 47.6 ± 1.5 weeks in the remaining five eyes. None of the patients developed complications such as cataract, glaucoma, retinal tear, retinal or vitreous hemorrhage, or retinal detachment. Conclusion: Although lower IVB doses in the treatment of AP-ROP are expected to be safer in terms of local and systemic side effects in premature infants, these patients may require additional treatment with IVB or laser photocoagulation.

RESUMO Líquen plano (LP) é uma doença auto-imune, inflamatória de etiologia desconhecida que normalmente afeta a pele e membranas mucosas. Vasculite retiniana engloba um grupo de doenças que ameaçam a visão em que a autoimunidade parece desempenhar um papel na sua patogênese. Apresentamos um caso que foi diagnosticado com vasculite da retina e que tinha sido acompanhado com LP de mucosa. LP não consta entre as causas de vasculite retiniana na literatura. Acreditamos que a vasculite da retina no nosso caso, foi relacionado com o LP considerando que a imunidade celular desempenha um papel na patogênese de ambas as entidades.

ABSTRACT Lichen planus (LP) is an autoimmune, inflammatory disease of unknown etiology that commonly affects the skin and mucous membranes. Retinal vasculitis is a group of vision-threatening disorders, in which autoimmunity is thought to play a role in pathogenesis. We present the case of a patient who was diagnosed with retinal vasculitis and who was followed up for mucosal LP. LP has not been reported as a cause of retinal vasculitis in the literature. We believe that the retinal vasculitis in this case was related to LP because cellular immunity plays a role in the pathogenesis of both entities.